Page last updated: 2024-12-07

emeriamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

emeriamine: derived from fungal metabolite emericedin; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121830
CHEMBL ID2114397
SCHEMBL ID3691259
MeSH IDM0132906

Synonyms (13)

Synonym
1-propanaminium, 2-amino-3-carboxy-n,n,n-trimethyl-, hydroxide, inner salt, (r)-
3-amino-4-trimethylaminobutyric acid
emeriamine
amino-carnitine
(3r)-3-amino-4-(trimethylammonio)butanoate
(3r)-3-amino-4-(trimethylazaniumyl)butanoate
bdbm50403034
chembl2114397 ,
SCHEMBL3691259
DTXSID00243410
DAWBGYHPBBDHMQ-ZCFIWIBFSA-N
(2r)-2-amino-3-carboxy-n,n,n-trimethyl-1-propanaminium inner salt
(r)-3-amino-4-(trimethylammonio)butanoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carnitine O-palmitoyltransferase 2, mitochondrialRattus norvegicus (Norway rat)IC50 (µMol)2.95000.38002.09335.1000AID719665; AID719698
Carnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)IC50 (µMol)3.90000.16002.03003.9000AID719674
Carnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)IC50 (µMol)76.40001.05001.05001.0500AID719720
Carnitine O-palmitoyltransferase 1, muscle isoformRattus norvegicus (Norway rat)IC50 (µMol)16.20000.38002.03255.1000AID719675; AID719698
Carnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)IC50 (µMol)63.65000.12594.244010.0000AID719675; AID719719
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (27)

Processvia Protein(s)Taxonomy
long-chain fatty acid metabolic processCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
in utero embryonic developmentCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
fatty acid beta-oxidationCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
carnitine shuttleCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
carnitine metabolic processCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
positive regulation of cold-induced thermogenesisCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
response to hypoxiaCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
long-chain fatty acid metabolic processCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
glucose metabolic processCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
fatty acid beta-oxidationCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
triglyceride metabolic processCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
carnitine shuttleCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
response to nutrientCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
response to xenobiotic stimulusCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
carnitine metabolic processCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
regulation of lipid storageCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
response to organic cyclic compoundCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
epithelial cell differentiationCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
positive regulation of fatty acid beta-oxidationCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
eating behaviorCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
response to alkaloidCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
positive regulation of innate immune responseCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
response to ethanolCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
aflatoxin metabolic processCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
regulation of insulin secretionCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
cellular response to fatty acidCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
liver regenerationCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
response to tetrachloromethaneCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
fatty acid metabolic processCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
fatty acid metabolic processCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
fatty acid beta-oxidationCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
carnitine shuttleCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
carnitine metabolic processCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
response to blue lightCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
long-chain fatty acid transportCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
carnitine O-palmitoyltransferase activityCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
protein bindingCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
carnitine O-octanoyltransferase activityCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
acyltransferase activityCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
carnitine O-palmitoyltransferase activityCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
protein-macromolecule adaptor activityCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
identical protein bindingCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
palmitoleoyltransferase activityCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
carnitine O-palmitoyltransferase activityCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
protein bindingCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
nucleoplasmCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
nucleolusCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
mitochondrionCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
mitochondrial inner membraneCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
mitochondrionCarnitine O-palmitoyltransferase 2, mitochondrialHomo sapiens (human)
mitochondrionCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
mitochondrial outer membraneCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
membraneCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
mitochondrionCarnitine O-palmitoyltransferase 1, liver isoformHomo sapiens (human)
mitochondrionCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
mitochondrial outer membraneCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
mitochondrionCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID719653Increase in plasma LDL level in fasted Wistar rat at 16 mg/kg, ip2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719674Inhibition of human CPT22011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719675Maximal inhibition of rat CPT1A2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719668Inhibition of carnitine palmitoyltransferase in 20 hrs fasted Sprague-Dawley rat liver mitochondria assessed as palmitoylcarnitine oxidation by radiometry2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719654Increase in plasma VLDL level in fasted Wistar rat at 16 mg/kg, ip2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID183229Inhibition of carnitine-dependent oxidation of [1-14C]palmitate to 14CO2 in rat liver mitochondria was measured in vitro at 2 nM concentration1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Chemistry and inhibitory activity of long chain fatty acid oxidation of emeriamine and its analogues.
AID719651Reduction in in plasma glucose level in fasted Wistar rat at 16 mg/kg, ip2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719665Inhibition of CPT2 in 24 hrs fasted rat liver mitochondria assessed as palmitoylcarnitine oxidation by radiometry2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719719Inhibition of human CPT1B2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719655Increase in plasma FFA level in fasted Wistar rat at 16 mg/kg, ip2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719720Inhibition of human CPT1A2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID183230Inhibition of carnitine-dependent oxidation of [1-14C]palmitate to 14CO2 in rat liver mitochondria was measured in vitro at 2*10e-1 mM concentration1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Chemistry and inhibitory activity of long chain fatty acid oxidation of emeriamine and its analogues.
AID719714Inhibition of carnitine palmitoyltransferase in rat mitochondria2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719656Increase in plasma TG level in fasted Wistar rat at 16 mg/kg, ip2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719664Reduction in palmitate oxidation in rat liver mitochondria at 18 mg/kg, ip administered as single dose measured 24 hrs post dose2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID183232Inhibition of carnitine-dependent oxidation of [1-14C]palmitate to 14CO2 in rat liver mitochondria was measured in vitro at 2*10e-3 mM concentration1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Chemistry and inhibitory activity of long chain fatty acid oxidation of emeriamine and its analogues.
AID719667Inhibition of carnitine palmitoyltransferase in 20 hrs fasted Sprague-Dawley rat liver mitochondria assessed as palmitate oxidation by radiometry2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719666Inhibition of carnitine palmitoyltransferase in 24 hrs fasted rat liver mitochondria assessed as palmitoylcarnitine oxidation by radiometry2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID183231Inhibition of carnitine-dependent oxidation of [1-14C]palmitate to 14CO2 in rat liver mitochondria was measured in vitro at 2*10e-2 mM concentration1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Chemistry and inhibitory activity of long chain fatty acid oxidation of emeriamine and its analogues.
AID719672Cytotoxicity in human KB cells2011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
AID719698Inhibition of rat CPT22011Journal of medicinal chemistry, May-12, Volume: 54, Issue:9
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (21.88)18.7374
1990's17 (53.13)18.2507
2000's4 (12.50)29.6817
2010's3 (9.38)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.17 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.67 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]